Reporting what happened in a meeting
Discussion:
Jack explains about current biologic pipeline ZETA, LUNA (both for arthritis rheumatoid) and X.
X is only there is a stability molecule end is possible start the registration process in 1 or 2 years.
Jack is interested in launching X on prefill syringe, but this decision must be made by a multi-professional team.
Jack mentioned there is expansion project for the injectables line and there is a desire to improve some primary packaging.
Next month we will plan a WorkShop for the entire team involved in injectable drugs., focused on information regarding the adaptation, support and interaction of our company with the filling machines.
多彩な 英語 講師陣から検索…

